Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Urology
|
November 29, 2016
Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience
Peter C Rubenwolf, Christian Hampel, Frederik Roos, et al.
Urologia Internationalis
|
April 15, 2015
Pancreatic Fistulae after Urologic Surgery - A Single Centre Experience
Sebastian Nestler, Andreas Neisius, Frederik Roos, et al.
Dermatologic Therapy
|
May 26, 2022
Hidradenitis suppurativa-Pitfalls of long-term immunosuppressive treatment with tumor necrosis factor (TNF)-α inhibitors
Kim Nikola Zeiner, Teresa Schreckenbach, Tatjana Gruber-Rouh, et al.
Anticancer Research
|
November 7, 2018
Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells
Jochen Rutz, Eva Juengel, Stephanie Euler, et al.
Complementary Therapies in Medicine
|
April 3, 2019
Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administration
Jens Mani, Jochen Rutz, Sebastian Maxeiner, et al.
Oncotarget
|
January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
Eva Juengel, Ramin Najafi, Jochen Rutz, et al.
Nutrition and Cancer
|
July 13, 2019
Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro
Jens Mani, Jens Neuschäfer, Christian Resch, et al.
Oncotarget
|
May 4, 2018
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma <i>in vitro</i>
Tobias Engl, Jochen Rutz, Sebastian Maxeiner, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
March 19, 2017
Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines
Eva Juengel, Stephanie Euler, Sebastian Maxeiner, et al.
Cells
|
September 12, 2018
HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Urology
|
November 29, 2016
Continent Anal Urinary Diversion in Classic Bladder Exstrophy: 45-Year Experience
Peter C Rubenwolf, Christian Hampel, Frederik Roos, et al.
Urologia Internationalis
|
April 15, 2015
Pancreatic Fistulae after Urologic Surgery - A Single Centre Experience
Sebastian Nestler, Andreas Neisius, Frederik Roos, et al.
Dermatologic Therapy
|
May 26, 2022
Hidradenitis suppurativa-Pitfalls of long-term immunosuppressive treatment with tumor necrosis factor (TNF)-α inhibitors
Kim Nikola Zeiner, Teresa Schreckenbach, Tatjana Gruber-Rouh, et al.
Anticancer Research
|
November 7, 2018
Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells
Jochen Rutz, Eva Juengel, Stephanie Euler, et al.
Complementary Therapies in Medicine
|
April 3, 2019
Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administration
Jens Mani, Jochen Rutz, Sebastian Maxeiner, et al.
Oncotarget
|
January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
Eva Juengel, Ramin Najafi, Jochen Rutz, et al.
Nutrition and Cancer
|
July 13, 2019
Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro
Jens Mani, Jens Neuschäfer, Christian Resch, et al.
Oncotarget
|
May 4, 2018
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma <i>in vitro</i>
Tobias Engl, Jochen Rutz, Sebastian Maxeiner, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
March 19, 2017
Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines
Eva Juengel, Stephanie Euler, Sebastian Maxeiner, et al.
Cells
|
September 12, 2018
HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Page
of 4